2 min read Health Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis August 29, 2025 timesofgujarat PENNINGTON, N.J., AHMEDABAD, INDIA, – August 29th, 2025 – Zydus Therapeutics, a wholly owned...
